Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07294118 · ClinicalTrials.gov registry record · Phase 2
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
A Phase 2 study of Opioid Use and Headache, sponsored by The University of Texas Medical Branch, Galveston.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07294118: Recruiting Phase 2 study of Opioid Use and Headache, sponsored by The University of Texas Medical Branch, Galveston.
NCT07294118 is a Phase 2 study of Opioid Use and Headache that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 15 participants, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07294118, a Phase 2 study of Opioid Use and Headache, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Primary Outcome
The Visual Analog Scale (VAS) is a validated, subjective measure for assessing pain intensity. It consists of a 10-centimeter horizontal line anchored by two extremes: "no pain" (0 mm) and "worst imaginable pain" (100 mm). Participants indicate their pain level by marking a point along the line that corresponds to their current pain intensity. The score is determined by measuring the distance in millimeters from the "no pain" anchor to the participant's mark, yielding a score between 0 and 100 m
Conditions Studied
Interventions
- DRUG Lidocaine
- DRUG Lidocaine and Dexamethasone
Study Locations (1)
Texas
- University of Texas Medical Branch, Galveston - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-01-02 |
| Est. Completion | 2027-08 |
| Phase | Phase 2 |
What NCT07294118 shows while recruiting
NCT07294118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine is the first listed.
NCT07294118 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07294118 about?
NCT07294118 is a clinical study titled "Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage". The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
What is the current status of trial NCT07294118?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2026-01-02. Estimated completion is 2027-08.
What conditions does trial NCT07294118 study?
This clinical trial studies the following conditions: Opioid Use, Headache, Opiate Dependence, Subarachnoid Hemorrhage, Aneurysmal.
What interventions are being tested in trial NCT07294118?
The interventions under investigation include: Lidocaine (DRUG), Lidocaine and Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT07294118?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07294118 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07294118's enrollment target sits among peer trials
15 104th of 105 higher than 2 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
RECRUITING · Phase 2
-
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
RECRUITING · Phase 2
-
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
ACTIVE NOT RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Managing Opioid Related Sleep Apnea With Acetazolamide
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI